This dual peptide blend combines CJC-1295 and Ipamorelin for complementary GH release with different durations of action. CJC-1295 is a tetrasubstituted GHRH analog with enhanced stability and extended half-life via albumin binding, while Ipamorelin is a selective GHS-R1a agonist. Research indicates applications in GH research, nitrogen balance, and lean mass studies.



Reviews
There are no reviews yet.